Release Date: 24/08/09 12:12 Summary: Earnings for the half year to 30 June 2009 Price Sensitive: Yes Download Document 42.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%